Study finds unique HIV vaccine formula elicits strong immune...(the University of Alabama-Birmingham. .....),Health
Navigation Links
Study finds unique HIV vaccine formula elicits strong immune responses
Date:5/22/2008
the University of Alabama-Birmingham.
'/>"/>
| Contact: Office of Public Affairs public.affairs@umassmed.edu 508-856-2000 University of Massachusetts Medical School Source:Eurekalert |
Related medicine news :
1. First of its kind study compares high school knee injuries by sport and gender
2. UNC study firms up promise of potential new cervical cancer screening tool
3. Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50
4. Study presented at DDW 2008 Confirms that New Device Significantly Improves Detection of Polyps in the Colon
5. Israeli study finds obstructive sleep apnea is health factor from day 1
6. Study finds that recalled Aqua Dots did contain poisonous chemical
7. Study reveals link among childhood allergies, asthma symptoms, and early life exposure to cats
8. Study analyzed SYMBICORT in children with persistent asthma
9. New patient satisfaction study with budesonide/formoterol combination therapy
10. Study: Doctors not always sure when to treat BP in people with diabetes
11. Study concludes no racial disparities in long-term outcomes in recipients of liver transplants
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 2Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 3Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 4Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 5Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 6Health News:Wellness Manufacturer Wins Two 2009 American Spa Awards 2Health News:NVHR Offers Congressman Hank Johnson Support & Encouragement as He Battles Chronic Hepatitis C Virus 2Health News:Americans United for Life Action Fights the Abortion Bailout by Supporting the Nelson-Hatch-Casey Amendment 2Health News:Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards 2Health News:Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards 3
[0] Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing[0] Wellness Manufacturer Wins Two 2009 American Spa Awards [1] NVHR Offers Congressman Hank Johnson Support & Encouragement as He Battles Chronic Hepatitis C Virus[0] Americans United for Life Action Fights the Abortion Bailout by Supporting the Nelson-Hatch-Casey Amendment[0] Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards
Other Medicine News:Health News:Maclaren Appoints New President and New Chief Operation Officer 2Health News:Expert Says Conseco Trust May Significantly Alter The Senior Health Care Market 2Health News:HeartSine Portable Defibrillator Donation Brings Added Safety to Habitat for Humanity of Charlotte ReStore Location 2Health News:assisTek's ePRO Biotech Clinical Trial Data Collection Saves Client $1.6 Million Over Paper Questionnaires 2Health News:Cherry-Enriched Diet Cut Heart Risks in Rats 2Health News:Birdstep Technology Adds Micro HTTP Server to the Upcoming Release of its Raima Database Manager, RDM Embedded Version 9.0 2Health News:Birdstep Technology Adds Micro HTTP Server to the Upcoming Release of its Raima Database Manager, RDM Embedded Version 9.0 3
Maclaren Appoints New President and New Chief Operation OfficerExpert Says Conseco Trust May Significantly Alter The Senior Health Care MarketHeartSine Portable Defibrillator Donation Brings Added Safety to Habitat for Humanity of Charlotte ReStore Location assisTek's ePRO Biotech Clinical Trial Data Collection Saves Client $1.6 Million Over Paper Questionnaires Cherry-Enriched Diet Cut Heart Risks in RatsBirdstep Technology Adds Micro HTTP Server to the Upcoming Release of its Raima Database Manager, RDM Embedded Version 9.0
Breaking Medicine Technology:CompuCyte Announces the Release of Four-Laser Imaging Cytometers 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 1DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 2DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 3DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 4DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 5DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 6DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 7DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 8DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 9DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 10DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 11DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 12DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 13Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 1Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 2Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 3Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 4Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 5Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 6Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 7Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 8Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 9Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 10Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 11Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 12Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 13Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 14Dr James OConnell Named J H Kanter Prize Laureate 54148 1Dr James OConnell Named J H Kanter Prize Laureate 54148 2Dr James OConnell Named J H Kanter Prize Laureate 54148 3
Other Medicine Technology:BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 5
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |